PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) shares fell 1.4% on Wednesday . The stock traded as low as $1.73 and last traded at $1.73. 2,000 shares changed hands during trading, an increase of 131% from the average session volume of 867 shares. The stock had previously closed at $1.7550.
PureTech Health Stock Down 1.4%
The firm’s 50 day simple moving average is $1.68 and its 200 day simple moving average is $1.69.
About PureTech Health
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Further Reading
- Five stocks we like better than PureTech Health
- A month before the crash
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Bitcoin is down but your income is about to explode
- Trump Devises the Death of the IRS ☠️
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
